Intracanal Dexamethasone Extrusion and Postoperative Endodontic Pain

Trial statusNot yet recruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity of Jordan

About this trial

The aim of this research is to assess the effect of intentionally extruding a corticosteroid intracanal solution into the periapical tissues on the postoperative pain after root canal treatment in patients with symptomatic irreversible pulpitis and symptomatic apical periodontitis (SIP/SAP). The main question it aims to answer: Is there an analgesic effect of extruding an intracanal solution of DXA into the periapical tissues in patients diagnosed with SIP/SAP? Researchers will compare dexamethasone to a placebo to see if the extrusion dexamethasone works in reducing post-endodontic treatment pain.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

A diagnosis of irreversible pulpits with symptomatic apical periodontitis

Adult patients (aged 18 - 70)

Healthy patients or those with a well-controlled disease (ASA I & II)

Disqualifiers

A diagnosis of necrotic pulp, or normal apical tissues

Patients with a severe systemic disease (ASA III or higher)

Patients who received analgesics12 hours before presentation

Previously treated/initiated Endodontics treatment on the same tooth

Trial design

Design model

Parallel

Treatments tested in this trial

  • Dexamethasone

    Drug

    a 2 ml solution of dexamethasone (3.3mg/ml) will be flushed in the root canal and intentionally extruded to the periradicular tissues to assess its potnetial sedative effect

  • Placebo

    Other intervention

    2ml of normal saline will be used as placebo to be flushed and extruded through the canals to the periradicular tissues

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: DXMExperimental treatment 1 intervention
Group B: SalinePlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Post-operative pain following root canal treatment

The outcome measure is patient-reported pain following root canal treatment. Patients will be given a questionnaire to complete, on 4 different time intervals following the completion of their root canal treatment (12, 24, 48 and 72 h). For each time interval, patients will be asked to fill out: 1. their perceived pain level on a standard 100mm visual-analogue scale, with pain values ranging from zero (no pain at all) and ascending gradually until 100 (worst imagined pain). 2. Whether they needed to take any analgesics. In this case, details about the type, route, dose and timing of the analgesic taken will have to be filled out

Time frame
at 12, 24, 48 and 72 hours after completing the treatment

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: